Feng Chi Biotech Corp. (6744.TWO)
TWD 19.7
(0.0%)
TWD 19.7
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -19.81 Million TWD | 62.2% |
| 2022 | -52.42 Million TWD | -13.33% |
| 2021 | -46.25 Million TWD | -10.1% |
| 2020 | -42.01 Million TWD | -20.12% |
| 2019 | -34.97 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -31.54 Million TWD | 6.9% |
| 2024 Q1 | -31.54 Million TWD | -59.22% |
| 2023 Q1 | -48.81 Million TWD | 6.88% |
| 2023 FY | -19.81 Million TWD | 62.2% |
| 2023 Q4 | -19.81 Million TWD | 11.79% |
| 2023 Q3 | -22.46 Million TWD | 51.27% |
| 2023 Q2 | -46.09 Million TWD | 5.57% |
| 2022 Q4 | -52.42 Million TWD | 4.87% |
| 2022 FY | -52.42 Million TWD | -13.33% |
| 2022 Q3 | -55.1 Million TWD | 0.0% |
| 2021 FY | -46.25 Million TWD | -10.1% |
| 2020 FY | -42.01 Million TWD | -20.12% |
| 2019 FY | - TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 162.287% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 164.795% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | 69.197% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 196.729% |
| NaviFUS Corp. | -123.12 Million TWD | 83.909% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | 85.242% |
| TaiRx, Inc. | -147.86 Million TWD | 86.601% |
| Sinew Pharma Inc. | -160.34 Million TWD | 87.644% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 99.384% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | 65.637% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 95.198% |
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | 74.284% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 92.5% |
| AP Biosciences Inc | -196.52 Million TWD | 89.918% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 97.089% |
| RBC Bioscience Corporation | 422.18 Million TWD | 104.693% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 106.292% |
| EirGenix Inc. | -4.58 Billion TWD | 99.568% |
| Enimmune corporation | -314.15 Million TWD | 93.693% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 139.037% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 97.902% |
| 3D Global Biotech Inc. | -11.43 Million TWD | -73.236% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 103.964% |
| Mycenax Biotech Inc. | 207 Million TWD | 109.571% |
| TCI GENE Inc. | -689.25 Million TWD | 97.125% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 92.455% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 95.224% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 90.535% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | 89.912% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | 86.228% |
| Neith Corporation | -150.31 Million TWD | 86.819% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 116.392% |
| VBI | -25.31 Million TWD | 21.737% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 94.006% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 149.205% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | 80.477% |
| CHO Pharma, Inc. | -203.79 Million TWD | 90.278% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 91.809% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | 83.342% |
| Visgeneer Inc. | 31.28 Million TWD | 163.333% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 94.127% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | 76.625% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 126.756% |
| Sagittarius Life Science Corp | -120.57 Million TWD | 83.567% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 93.758% |
| GlycoNex Incorporation | -148.56 Million TWD | 86.664% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 102.877% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 97.612% |
| PharmaEngine, Inc. | -860.8 Million TWD | 97.698% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 101.46% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 114.358% |
| BiOptic Inc. | 12.59 Million TWD | 257.346% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 93.395% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 98.487% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | 80.551% |
| OBI Pharma, Inc. | -398.22 Million TWD | 95.025% |
| Savior Lifetec Corporation | -812.54 Million TWD | 97.562% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 88.005% |
| Level Biotechnology Inc. | -453.9 Million TWD | 95.635% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 103.188% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 94.578% |
| Acepodia, Inc. | -6.02 Billion TWD | 99.671% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 99.418% |